Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2016 Q2- Text added to 2016 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
Allergan, biomarker, CII, cirrhotic, cleaved, cohort, culture, Division, driven, extinguishment, feature, gender, hsCRP, implicated, inflammatory, larger, length, marker, mediator, pronounced, Protein, protocol, regimen, sensitivity, temporal, therapy, unqualified, write, wrote
Removed:
abroad, advertising, bifurcated, conditionally, country, derivative, dysfunction, embedded, encounter, endotoxin, epigenomic, eventually, exercisable, fatty, fulfilled, govern, hepatic, instrument, insufficient, interpret, interrelated, lieu, NAFLD, outlined, pertain, point, promotion, reach, rigorously, satisfactory, scale, shock, shorter, substituted, unproven, vary
Valuein 2016 Q2 filing- Value in 2016 Q3 filing
Original filings
Filing view